Postcard from Palm Springs 2024

The Postcards are a series of short videos aimed at non-scientists that convey the major themes, scientific breakthroughs, and clinical trial updates from each year’s Huntington’s Disease Therapeutics Conference held (most usually) in Palm Springs, California. Beginning in 2006, this series of conferences is a unique forum where researchers from academia meet with pharmaceutical and biotechnology company colleagues to discuss their latest progress, share ideas, and spark new collaborations. If you would like to post this or any other of these Postcards on your website, please contact

Evotec and CHDI Foundation extend strategic drug discovery collaboration in Huntington’s disease

Hamburg, Germany, 28 May 2024:
Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) has announced the extension of its 20-year collaboration with CHDI Foundation, Inc. (“CHDI”). CHDI is a privately funded nonprofit biomedical research organization exclusively dedicated to collaboratively developing therapeutics that will substantially improve the lives of those affected by Huntington’s disease. The collaboration will further our fundamental scientific understanding of the disease and thereby aid the development of new effective treatments.

Read more…